Azenta, Inc. (NASDAQ:AZTA) Shares Acquired by LPL Financial LLC

LPL Financial LLC boosted its holdings in Azenta, Inc. (NASDAQ:AZTA - Free Report) by 31.4% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 50,342 shares of the company's stock after acquiring an additional 12,033 shares during the quarter. LPL Financial LLC owned about 0.11% of Azenta worth $2,590,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently bought and sold shares of AZTA. Ballentine Partners LLC increased its stake in Azenta by 2.0% in the 4th quarter. Ballentine Partners LLC now owns 20,340 shares of the company's stock valued at $1,017,000 after purchasing an additional 404 shares in the last quarter. Picton Mahoney Asset Management grew its holdings in Azenta by 305.7% in the fourth quarter. Picton Mahoney Asset Management now owns 706 shares of the company's stock valued at $35,000 after purchasing an additional 532 shares during the last quarter. KBC Group NV increased its position in shares of Azenta by 48.5% in the fourth quarter. KBC Group NV now owns 2,137 shares of the company's stock valued at $107,000 after buying an additional 698 shares in the last quarter. Oregon Public Employees Retirement Fund raised its stake in shares of Azenta by 7.0% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 10,700 shares of the company's stock worth $535,000 after buying an additional 702 shares during the last quarter. Finally, Quantinno Capital Management LP boosted its position in shares of Azenta by 31.3% in the 3rd quarter. Quantinno Capital Management LP now owns 8,526 shares of the company's stock worth $413,000 after buying an additional 2,033 shares in the last quarter. Institutional investors and hedge funds own 99.08% of the company's stock.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on the stock. TD Cowen upgraded shares of Azenta to a "hold" rating in a research report on Thursday, February 27th. Evercore ISI lifted their price objective on Azenta from $50.00 to $52.00 and gave the stock an "in-line" rating in a research report on Thursday, February 6th. Stephens reiterated an "overweight" rating and set a $60.00 target price on shares of Azenta in a report on Thursday, January 2nd. Finally, Needham & Company LLC raised their price target on Azenta from $55.00 to $59.00 and gave the stock a "buy" rating in a research report on Thursday, February 6th.

Azenta Trading Down 1.0 %

Shares of NASDAQ AZTA traded down $0.25 during midday trading on Friday, reaching $25.25. 880,637 shares of the stock were exchanged, compared to its average volume of 638,591. The stock has a 50 day moving average price of $36.94 and a 200-day moving average price of $43.99. The company has a market capitalization of $1.15 billion, a P/E ratio of -8.47 and a beta of 1.66. Azenta, Inc. has a 52-week low of $24.68 and a 52-week high of $63.58.

Azenta (NASDAQ:AZTA - Get Free Report) last released its earnings results on Wednesday, February 5th. The company reported $0.08 EPS for the quarter, topping the consensus estimate of $0.05 by $0.03. Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. On average, analysts forecast that Azenta, Inc. will post 0.53 earnings per share for the current year.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.